NASDAQ · Medical - Healthcare Information Services

Mangoceuticals, Inc. (MGRX) Stock

$0.42 -2.41% NASDAQ: MGRX Healthcare

Valuation

MetricValue
Price$0.42
Market Cap$7.16M
P/E Ratio-0.36
P/B Ratio0.57
P/S Ratio22.50
EPS (TTM)$-2.05
52-Week High$2.75
52-Week Low$0.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-106.12%
ROA-106.57%
ROCE-103.27%
Gross Margin52.42%
Operating Margin-42.04%
Net Margin-46.33%
Debt/Equity0.03
Current Ratio2.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$1.0M$1.0M$0
Operating Profit$0$-2.0M$-9.0M$-8.0M$-19.0M
Net Profit$0$-2.0M$-9.0M$-9.0M$-21.0M
EPS$-0.02$-1.73$-6.45$-4.40$-2.17
Op Margin—-22279.7%-1260.3%-1294.4%-4200.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$1.0M$1.0M$15.0M$16.0M
Total Liabilities$0$0$0$1.0M$1.0M
Cash$0$1.0M$1.0M$0$1.0M
Borrowings$0$0$0$0$0

Latest News

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology GlobeNewswire · Jul 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-1.0M$-7.0M$-5.0M$-6.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$1.0M$1.0M$1.0M
Net Cash Flow$0$1.0M$0$-1.0M$1.0M
Free Cash Flow$0$-1.0M$-7.0M$-5.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.52
FCF Yield-54.86%
Quick Ratio0.18
Interest Coverage-20.23
Return 1Y-74.52%
Return 3Y-98.51%
Return 5Y—

Ownership

Insiders Held10.04%
Institutions Held4.97%
Institutions Float Held5.53%
Institutional HolderSharesReport Date
Geode Capital Management, LLC194,4822026-03-31
Ikarian Capital, LLC138,1462026-03-31
Vanguard Capital Management LLC123,0412026-03-31
Jane Street Group, LLC72,7462026-03-31
Virtu Financial LLC61,0282026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ASBPAspire-Lakewood Holdings, Inc. $8.30 +0.00% -1.03 $957588 0.00%
CASICASI Pharmaceuticals, Inc. $0.15 +3.08% -0.07 $2.33M 0.00%
CINGCingulate Inc. $4.89 +0.20% -0.95 $65.86M 0.00%
CLSDClearside Biomedical, Inc. $0.41 +0.00% -0.11 $2.15M 0.00%
ENTOEntero Therapeutics, Inc. $2.85 -5.00% -0.82 $13.58M 0.00%

About Mangoceuticals, Inc.

Mangoceuticals, Inc. is led by CEO Jacob D. Cohen, employs 3 people, headquartered in US, publicly traded since 2023.

Mangoceuticals, Inc. (MGRX) stock trades at $0.42 with a market capitalization of $7.16M. The stock is valued at a price-to-earnings (P/E) ratio of -0.36, price-to-book of 0.57, price-to-sales of 22.50. Over the past 52 weeks the stock has ranged between $0.16 and $2.75, and currently trades 84.7% below its 52-week high.

On profitability, Mangoceuticals, Inc. generates a return on equity (ROE) of -106.12%, return on capital employed of -103.27%, an operating margin of -42.04%, a net profit margin of -46.33%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides